Recent publications
Article
UK-PBC audit group 2024, 'Critical shortfalls in the management of PBC: Results of a UK-wide, population-based evaluation of care delivery', JHEP Reports, vol. 6, no. 1, 100931. https://doi.org/10.1016/j.jhepr.2023.100931
the OCTAVE Collaborative Group, PITCH study, and the EASL supported COVID-Hep vaccine network, Murray, SM, Pose, E, Wittner, M, Londoño, MC, Schaub, G, Cook, J, Dimitriadis, S, Meacham, G, Irwin, S, Lim, Z, Duengelhoef, P, Sterneck, M, Lohse, AW, Perez, V, Trivedi, P, Bhandal, K, Mullish, BH, Manousou, P, Provine, NM, Avitabile, E, Carroll, M, Tipton, T, Healy, S, Burra, P, Klenerman, P, Dunachie, S, Kronsteiner, B, Maciola, AK, Pasqual, G, Hernandez-Gea, V, Garcia-Pagan, JC, Lampertico, P, Iavarone, M, Gines, P, Lütgehetmann, M, Schulze zur Wiesch, J, Russo, FP, Barnes, E & Marjot, T 2024, 'Immune responses and clinical outcomes after COVID-19 vaccination in patients with liver disease and liver transplant recipients', Journal of Hepatology, vol. 80, no. 1, pp. 109-123. https://doi.org/10.1016/j.jhep.2023.10.009
Trivedi, PJ, Arndtz, K, Abbas, N, Telford, A, Young, L, Banerjee, R, Eddowes, P, Jhaveri, KS & Hirschfield, GM 2024, 'Quantitative MRCP and metrics of bile duct disease over time in patients with primary sclerosing cholangitis: A prospective study', Alimentary Pharmacology & Therapeutics, pp. 1-10. https://doi.org/10.1111/apt.17944
Greenman, R, Segal-Salto, M, Barashi, N, Hay, O, Katav, A, Levi, O, Vaknin, I, Aricha, R, Aharoni, S, Snir, T, Mishalian, I, Olam, D, Amer, J, Salhab, A, Safadi, R, Maor, Y, Trivedi, P, Weston, CJ, Saffioti, F, Hall, A, Pinzani, M, Thorburn, D, Peled, A & Mor, A 2023, 'CCL24 regulates biliary inflammation and fibrosis in primary sclerosing cholangitis', JCI Insight, vol. 8, no. 12, e162270. https://doi.org/10.1172/jci.insight.162270
ESOT Guidelines Taskforce 2023, 'Liver Transplantation for Primary Sclerosing Cholangitis (PSC) With or Without Inflammatory Bowel Disease (IBD)—A European Society of Organ Transplantation (ESOT) Consensus Statement', Transplant international, vol. 36, 11729. https://doi.org/10.3389/ti.2023.11729
IAIHG and EASL DHILI Consortium 2023, 'Nomenclature, Diagnosis and Management of Drug-induced Autoimmune-like hepatitis (DI-ALH): An expert opinion meeting report', Journal of Hepatology, vol. 79, no. 3, pp. 853-866. https://doi.org/10.1016/j.jhep.2023.04.033
Mayo, MJ, Vierling, JM, Bowlus, CL, Levy, C, Hirschfield, GM, Neff, GW, Galambos, MR, Gordon, SC, Borg, BB, Harrison, SA, Thuluvath, PJ, Goel, A, Shiffman, ML, Swain, MG, Jones, DEJ, Trivedi, P, Kremer, AE, Aspinall, RJ, Sheridan, DA, Dörffel, Y, Yang, K, Choi, YJ & McWherter, CA 2023, 'Open‐label, clinical trial extension: Two‐year safety and efficacy results of seladelpar in patients with primary biliary cholangitis', Alimentary Pharmacology & Therapeutics. https://doi.org/10.1111/apt.17755
Abbas, N, Culver, EL, Thorburn, D, Halliday, N, Crothers, H, Dyson, JK, Phaw, A, Aspinall, R, Khakoo, SI, Kallis, Y, Smith, B, Patanwala, I, McCune, A, Chimakurthi, CR, Hegade, V, Orrell, M, Jones, R, Mells, G, Thain, C, Thain, R-M, Jones, D, Hirschfield, G & Trivedi, PJ 2023, 'UK-Wide Multicenter Evaluation of Second-line Therapies in Primary Biliary Cholangitis', Clinical Gastroenterology and Hepatology, vol. 21, no. 6, pp. 1561-1570.e13. https://doi.org/10.1016/j.cgh.2022.07.038
UK-PBC audit collaborators 2022, 'The national audit of primary biliary cholangitis (PBC) in the United Kingdom: defining the audit dataset and data collection system', Cureus, vol. 14, no. 6, e25609. https://doi.org/10.7759/cureus.25609
Trivedi, PJ, Crothers, H, Mytton, J, Bosch, S, Iqbal, T, Ferguson, J & Hirschfield, GM 2020, 'Effects of primary sclerosing cholangitis on risks of cancer and death in people with inflammatory bowel diseases, based on sex, race, and age', Gastroenterology, vol. 159, no. 3, pp. 915-928. https://doi.org/10.1053/j.gastro.2020.05.049
International Primary Sclerosing Cholangitis Study Group (IPSCSG) 2020, 'Effects of vedolizumab in patients with primary sclerosing cholangitis and inflammatory bowel diseases', Clinical Gastroenterology and Hepatology, vol. 18, no. 1, pp. 179-187.e6. https://doi.org/10.1016/j.cgh.2019.05.013
Global PBC Study Group 2020, 'Goals of treatment for improved survival in primary biliary cholangitis: treatment target should be bilirubin within the normal range and normalization of alkaline phosphatase', The American Journal of Gastroenterology, vol. 115, no. 7, pp. 1066-1074. https://doi.org/10.14309/ajg.0000000000000557
Trivedi, PJ, Muir, AJ, Levy, C, Bowlus, CL, Manns, M, Lu, X, Crans, G, Chung, C, Subramanian, GM, Myers, RP, Goodman, Z, Chalasani, N, Vierling, JM, Guha, IN & Hirschfield, GM 2020, 'Inter- and intra-individual variation, and limited prognostic utility, of serum alkaline phosphatase in a trial of patients with primary sclerosing cholangitis', Clinical Gastroenterology and Hepatology, vol. 2020. https://doi.org/10.1016/j.cgh.2020.07.032
Abstract
Freer, A, Williams, F, Durman, S, Hayden, J, Armstrong, M & Trivedi, P 2022, 'Home-based exercise in patients with refractory fatigue associated primary biliary cholangitis: final results from the EXerCise Intervention in cholesTatic LivEr Disease (EXCITED) clinical trial', Journal of Hepatology, vol. 77, no. Supplement 1, pp. S334-S335. https://doi.org/10.1016/S0168-8278(22)01032-7
Review article
Ricciuto, A, Kamath, BM, Hirschfield, GM & Trivedi, PJ 2023, 'Primary sclerosing cholangitis and overlap features of autoimmune hepatitis: A coming of age or an age-ist problem?', Journal of Hepatology, vol. 79, no. 2, pp. 567-575. https://doi.org/10.1016/j.jhep.2023.02.030
View all publications in research portal